{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2022-06-09T18:06:49.000+02:00"
            }
        ],
        "firstPublicationDate": "2022-06-09T18:06:49.000+02:00",
        "lastUpdateDate": "2024-05-27T14:26:50.000+02:00",
        "registerEntryVersions": [
            {
                "legislation": "GL2024",
                "registerEntryId": 31738,
                "validFromDate": "2024-05-27T14:26:50.000+02:00",
                "version": 4,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2024",
                "registerEntryId": 29966,
                "validFromDate": "2024-03-04T16:06:29.000+01:00",
                "validUntilDate": "2024-05-27T14:26:50.000+02:00",
                "version": 3,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 23344,
                "validFromDate": "2023-07-10T08:13:17.000+02:00",
                "validUntilDate": "2024-03-04T16:06:29.000+01:00",
                "version": 2,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 6948,
                "validFromDate": "2022-06-09T18:06:49.000+02:00",
                "validUntilDate": "2023-07-10T08:13:17.000+02:00",
                "version": 1,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": true,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_NETWORK_WITHOUT_LEGAL_FORM",
            "de": "Plattform, Netzwerk, Interessengemeinschaft, Denkfabrik, Initiative, Aktionsb\u00fcndnis o.\u00a0\u00e4.",
            "en": "Platform, network, community of interest, think tank, initiative, action alliance"
        },
        "activityDescription": "Das Ziel des DNAMR ist es, insbesondere die deutsche Politik \u00fcber die Dringlichkeit des Themas Antibiotikaresistenzen (AMR) zu informieren, daf\u00fcr zu sensibilisieren und gemeinsam an geeigneten L\u00f6sungen zu arbeiten. Das DNAMR ist davon \u00fcberzeugt, dass geeignete Instrumentarien gefunden und zur Anwendung kommen m\u00fcssen. Dabei sollten sowohl Push (Forschungsf\u00f6rderung) und Pull (Marktanreize) Modelle zum Einsatz kommen, um einerseits die Grundlagenforschung zu beleben und zu st\u00e4rken und andererseits Anreize f\u00fcr die Pharmaunternehmen zu schaffen, in neue Antibiotika zu investieren. Ziel ist es, das gesamte \u00f6konomische System der Erforschung und Entwicklung neuer Antibiotika so zu st\u00e4rken, dass in den n\u00e4chsten 15 Jahren zehn bis f\u00fcnfzehn neue Antibiotika entwickelt und vermarktet werden. \r\n\r\n",
        "fieldsOfInterest": [
            {
                "code": "FOI_HEALTH_MEDICINE",
                "de": "Arzneimittel",
                "en": "Medicine"
            },
            {
                "code": "FOI_HEALTH",
                "de": "Gesundheit",
                "en": "Health"
            }
        ],
        "typesOfExercisingLobbyWork": [
            {
                "code": "SELF_OPERATED_OWN_INTEREST",
                "de": "Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen",
                "en": "Interest representation is self-performed in its own interest"
            }
        ]
    },
    "annualReports": {
        "annualReportPreviousLastFiscalYearExists": false
    },
    "codeOfConduct": {
        "ownCodeOfConduct": false
    },
    "contracts": {
        "contracts": [],
        "contractsPresent": false
    },
    "donators": {
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalDonationsEuro": {
            "from": 0,
            "to": 0
        }
    },
    "employeesInvolvedInLobbying": {
        "employeeFTE": 0.5,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 20001,
            "to": 30000
        },
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "legislation": "GL2024",
    "lobbyistIdentity": {
        "address": {
            "city": "Berlin ",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "nationalAdditional1": "c/o g+h communication ",
            "street": "Leibnizstra\u00dfe ",
            "streetNumber": "28",
            "type": "NATIONAL",
            "zipCode": "10625"
        },
        "capitalCityRepresentationPresent": false,
        "contactDetails": {
            "emails": [
                {
                    "email": "amr-all@gundh.com"
                }
            ],
            "phoneNumber": "+4923624602",
            "websites": [
                {
                    "website": "dnamr.de"
                }
            ]
        },
        "entrustedPersons": [
            {
                "firstName": "Annette",
                "lastName": "Hornung-Pickert",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Rhan",
                "lastName": "Gunderlach",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "entrustedPersonsPresent": true,
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_OTHER_JP_INTERNATIONAL",
            "de": "Sonstige juristische Person, auch nach anderem als deutschem Recht",
            "en": "Other juristic person",
            "legalFormText": "Netzwerk"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "academicDegreeBefore": "Dr.",
                "entrustedPerson": false,
                "firstName": "Timo",
                "function": "Sprecher",
                "lastName": "J\u00e4ger",
                "recentGovernmentFunctionPresent": false
            },
            {
                "entrustedPerson": false,
                "firstName": "Harald",
                "function": "Sprecher",
                "lastName": "ZImmer",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Prof. Dr.",
                "entrustedPerson": false,
                "firstName": "Mathias",
                "function": "Mitglied",
                "lastName": "Pletz",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Dr.",
                "entrustedPerson": false,
                "firstName": "Marc",
                "function": "Mitglied",
                "lastName": "Gitzinger",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Dr.",
                "entrustedPerson": false,
                "firstName": "Ralf",
                "function": "Mitglied",
                "lastName": "Sudbrak",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "membersCount": {
            "dateCount": "2024-03-04",
            "naturalPersons": 1,
            "organizations": 7,
            "totalCount": 8
        },
        "membersPresent": true,
        "membershipsPresent": false,
        "name": "Deutsches Netzwerk gegen Antimikrobielle Resistenzen"
    },
    "mainFundingSources": {
        "mainFundingSources": [
            {
                "code": "MFS_OTHERS",
                "de": "Sonstiges",
                "en": "Others"
            }
        ],
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "membershipFees": {
        "individualContributors": [
            {
                "name": "vfa"
            }
        ],
        "individualContributorsPresent": true,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalMembershipFees": {
            "from": 20001,
            "to": 30000
        }
    },
    "publicAllowances": {
        "publicAllowancesPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "registerEntryDetails": {
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R004753/31738",
        "fiscalYearUpdate": {
            "lastFiscalYearUpdate": "2024-03-04T16:06:29.000+01:00"
        },
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/a5/18/277673/Lobbyregister-Detailansicht-R004753-2024-05-27_14-26-50.pdf",
        "validFromDate": "2024-05-27T14:26:50.000+02:00",
        "version": 4
    },
    "registerEntryId": 31738,
    "registerNumber": "R004753",
    "regulatoryProjects": {
        "regulatoryProjects": [
            {
                "affectedLaws": [],
                "affectedLawsPresent": false,
                "description": "Im EU-Pharmapaket werden u.a. Anreizmechanismen zur Entwicklung von neuen Antibiotika diskutiert. Das DNAMR setzt sich daf\u00fcr ein, dass die EU konkrete Anreizmechanismen , sei es die TEVs oder das Netflix Modell aufnimmt. Beim TEV Modell erhalten Unternehmen, einen Gutschein, bzw. eine Verl\u00e4ngerung eines Medikaments um die Kosten f\u00fcr die Entwicklung und Bereithaltung eines Antibiotikums gegen zu finanzieren. ",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_MEDICINE",
                        "de": "Arzneimittel",
                        "en": "Medicine"
                    }
                ],
                "printedMatters": [],
                "printedMattersPresent": false,
                "regulatoryProjectNumber": "RV0001005",
                "statements": [],
                "title": "Verordnung im Rahmen der EU General Pharmaceutical Legislative Revision"
            }
        ],
        "regulatoryProjectsPresent": true
    },
    "statements": {
        "statements": [],
        "statementsPresent": false
    }
}